Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease.

Dige A, Støy S, Rasmussen TK, Kelsen J, Hvas CL, Sandahl TD, Dahlerup JF, Deleuran B, Agnholt J.

J Crohns Colitis. 2013 Apr;7(3):248-55. doi: 10.1016/j.crohns.2012.06.015.

PMID:
22784949
2.

Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.

Liu C, Xia X, Wu W, Wu R, Tang M, Chen T, Xu F, Cong Y, Xu X, Liu Z.

Clin Exp Immunol. 2013 Jul;173(1):102-11. doi: 10.1111/cei.12084.

3.

TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis.

Wedebye Schmidt EG, Larsen HL, Kristensen NN, Poulsen SS, Lynge Pedersen AM, Claesson MH, Pedersen AE.

Inflamm Bowel Dis. 2013 Jul;19(8):1567-76. doi: 10.1097/MIB.0b013e318286fa1c.

PMID:
23689808
4.

Circulating CD4(+)CXCR5(+) T Cells Exacerbate B Cell Antibody Production in Crohn's Disease Through IL-21 Secretion.

Wang Z, Ding L, Wang Z, Wang J, Zhu N, Diao Y, Demmy TA, Haitsma JM, Lech-Maranda EE, Bangia NN, Czuczman MA, Qian X, Kovacs KL.

Immunol Invest. 2015;44(7):665-77. doi: 10.3109/08820139.2015.1074246.

PMID:
26436852
5.

Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease.

Jiang W, Su J, Zhang X, Cheng X, Zhou J, Shi R, Zhang H.

Inflamm Res. 2014 Nov;63(11):943-50. doi: 10.1007/s00011-014-0768-7.

PMID:
25129403
6.

Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.

Ueno A, Jijon H, Chan R, Ford K, Hirota C, Kaplan GG, Beck PL, Iacucci M, Fort Gasia M, Barkema HW, Panaccione R, Ghosh S.

Inflamm Bowel Dis. 2013 Nov;19(12):2522-34. doi: 10.1097/MIB.0b013e3182a85709.

PMID:
24097227
7.

Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells.

Dige A, Hvas CL, Deleuran B, Kelsen J, Bendix-Struve M, Dahlerup JF, Agnholt J.

Scand J Gastroenterol. 2011 Oct;46(10):1206-14. doi: 10.3109/00365521.2011.603157.

PMID:
21793633
8.

CD4+CD161+ T lymphocytes infiltrate Crohn's disease-associated perianal fistulas and are reduced by anti-TNF-α local therapy.

Maggi L, Capone M, Giudici F, Santarlasci V, Querci V, Liotta F, Ficari F, Maggi E, Tonelli F, Annunziato F, Cosmi L.

Int Arch Allergy Immunol. 2013;161(1):81-6. doi: 10.1159/000343467.

PMID:
23257766
9.

Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status.

Schmechel S, Konrad A, Diegelmann J, Glas J, Wetzke M, Paschos E, Lohse P, Göke B, Brand S.

Inflamm Bowel Dis. 2008 Feb;14(2):204-12.

PMID:
18022867
10.

Distinct profiles of effector cytokines mark the different phases of Crohn's disease.

Zorzi F, Monteleone I, Sarra M, Calabrese E, Marafini I, Cretella M, Sedda S, Biancone L, Pallone F, Monteleone G.

PLoS One. 2013;8(1):e54562. doi: 10.1371/journal.pone.0054562.

11.

Monocyte-derived dendritic cells from Crohn's disease patients exhibit decreased ability to activate T helper type 17 responses in memory cells.

Nieminen JK, Sipponen T, Färkkilä M, Vaarala O.

Clin Exp Immunol. 2014 Jul;177(1):190-202. doi: 10.1111/cei.12326.

12.

Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease.

Truchetet ME, Brembilla NC, Montanari E, Allanore Y, Chizzolini C.

Arthritis Res Ther. 2011;13(5):R166. doi: 10.1186/ar3486.

13.

Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.

Globig AM, Hennecke N, Martin B, Seidl M, Ruf G, Hasselblatt P, Thimme R, Bengsch B.

Inflamm Bowel Dis. 2014 Dec;20(12):2321-9. doi: 10.1097/MIB.0000000000000210.

PMID:
25248005
14.

Distinctive pattern of cytokine production and adhesion molecule expression in peripheral blood memory CD4+ T cells from patients with active Crohn's disease.

García de Tena J, Manzano L, Leal JC, San Antonio E, Sualdea V, Alvarez-Mon M.

J Clin Immunol. 2006 May;26(3):233-42.

PMID:
16783463
15.

Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.

Beltrán CJ, Candia E, Erranz B, Figueroa C, Gonzalez MJ, Quera R, Hermoso MA.

Eur Cytokine Netw. 2009 Mar;20(1):33-8. doi: 10.1684/ecn.2009.0142. Erratum in: Eur Cytokine Netw. 2009 Jun;20(2):94.

16.

Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.

Veny M, Esteller M, Ricart E, Piqué JM, Panés J, Salas A.

Aliment Pharmacol Ther. 2010 Mar;31(5):561-72. doi: 10.1111/j.1365-2036.2009.04209.x.

17.

The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels.

Babaloo Z, Aliparasti MR, Babaiea F, Almasi S, Baradaran B, Farhoudi M.

Immunol Lett. 2015 Apr;164(2):76-80. doi: 10.1016/j.imlet.2015.01.001.

PMID:
25625963
18.

Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease.

Agnholt J, Kelsen J, Schack L, Hvas CL, Dahlerup JF, Sørensen ES.

Scand J Immunol. 2007 May;65(5):453-60.

19.

IL-22+ CD4+ T cells in patients with rheumatoid arthritis.

Zhao L, Jiang Z, Jiang Y, Ma N, Zhang Y, Feng L, Wang K.

Int J Rheum Dis. 2013 Oct;16(5):518-26. doi: 10.1111/1756-185X.12099.

PMID:
24164838
20.

TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.

Olsen T, Rismo R, Cui G, Goll R, Christiansen I, Florholmen J.

Cytokine. 2011 Dec;56(3):633-40. doi: 10.1016/j.cyto.2011.08.036.

PMID:
21945121

Supplemental Content

Support Center